bullish

Lunit

Lunit IPO Preview: A Pioneer in AI-Based Cancer Diagnosis and Treatment Solutions

461 Views20 Jun 2022 19:42
Lunit is getting ready to complete its IPO in Korea in July. Lunit is one of the leading companies in Korea that specializes in AI-based cancer diagnosis and treatment solutions.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 9-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top 5%
Douglas Kim
Korea/Asia, Events, IPOs
Douglas Research Advisory
South KoreaEquity Bottom-UpEquity Capital Markets
Price Chart(Sign Up to Access)
analytics-chart
x